Retevmo
RxNorm concept 2370165, brand name (bn).
- RxCUI
- 2370165
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2370165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- selpercatinib 40 MG [Retevmo] (SBDC, ingredient of)
- selpercatinib Oral Capsule [Retevmo] (SBDF, ingredient of)
- Retevmo Oral Product (SBDG, ingredient of)
- Retevmo Pill (SBDG, ingredient of)
- selpercatinib 40 MG Oral Capsule [Retevmo] (SBD, ingredient of)
- selpercatinib 80 MG [Retevmo] (SBDC, ingredient of)
- selpercatinib 80 MG Oral Capsule [Retevmo] (SBD, ingredient of)
- selpercatinib 120 MG [Retevmo] (SBDC, ingredient of)
- selpercatinib Oral Tablet [Retevmo] (SBDF, ingredient of)
- selpercatinib 120 MG Oral Tablet [Retevmo] (SBD, ingredient of)
- selpercatinib 160 MG [Retevmo] (SBDC, ingredient of)
- selpercatinib 160 MG Oral Tablet [Retevmo] (SBD, ingredient of)
- selpercatinib 40 MG Oral Tablet [Retevmo] (SBD, ingredient of)
- selpercatinib 80 MG Oral Tablet [Retevmo] (SBD, ingredient of)
- selpercatinib (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2370165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2370165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2370165. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.